obesity-995x60.png
FEATURED ARTICLES
Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious Therapies
John Yu, MD, of Kairos Pharma, explains why reversing treatment resistance could extend the life of proven cancer therapies and improve patient outcomes.
-
![Fda Headquarters-GettyImages-2211199138]( "In Case You Missed Them: Recapping The FDA's Recent Guidances For Cell And Gene Therapies")
In Case You Missed Them: Recapping The FDA's Recent Guidances For Cell And Gene TherapiesI review 10 of the FDA’s guidances spanning the last 12 months, all of which aid cell and gene therapy companies to assure safety and efficacy of these medicines.
-
![Mixing medications-GettyImages-907865696]( "Repurposing Three FDA-Approved Drugs For A New Stroke Recovery Strategy")
Repurposing Three FDA-Approved Drugs For A New Stroke Recovery StrategyWhen three drugs become one — the polypharmacology strategy, 505(b)(2) pathway, and objective endpoints Nuero-Innovators is relying on to bring new hope to stroke patients.
-
![Business process direction-GettyImages-2282954232]( "Before Adding AI, Fix The Process")
Before Adding AI, Fix The ProcessRegeneron’s Kaniel Cassady argues that “doing more with less” in clinical development should start with questioning existing processes, unnecessary data collection, and outdated workflows before turning to AI and other new technologies.
SERVICES AND PRODUCTS
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.
YpsoDose supports a broad range of formulation and injection requirements. Its intuitive design ensures reliable, comfortable injections across conditions and environments.
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
From enabling connected clinical trials to supporting digital therapy management, our solutions help improve clinical trial operational efficiency and data quality, strengthen commercial success, and empower patients to self-manage their therapy.
With experience across 360+ rare disease studies and 125+ indications, explore how specialized expertise and patient-focused delivery help advance clinical programs.
CentrePoint is Ametris' robust, cloud software platform designed for collecting, processing, and managing real-world digital endpoint data in clinical investigations.